<DOC>
	<DOCNO>NCT00528437</DOCNO>
	<brief_summary>The purpose study : Find safe effective ( monitor good and/or bad effect ) treatment high dose temozolomide , thiotepa carboplatin stem cell rescue follow 13-cis-retinoic acid child adolescent recurrent/refractory brain tumor Find body use 13-cis-retinoic acid study blood level proteins blood break 13-cis-retinoic acid Determine well 13-cis-retinoic acid penetrate spinal fluid .</brief_summary>
	<brief_title>Temozolomide , Thiotepa Carboplatin With Autologous Stem Cell Rescue Followed 13-cis-retinoic Acid Patients With Recurrent/Refractory Malignant Brain Tumors</brief_title>
	<detailed_description>Researchers use high dos combination chemotherapy follow stem cell rescue treat recurrent brain tumor moderate success . High dose chemotherapy stem cell rescue result long term survival 25 % patient several different type recurrent brain tumor . Stem cell cell bone marrow produce blood cell . The stem cell collect blood patient high dose chemotherapy . Patients give high dos chemotherapy kill every brain tumor cell , process cell bone marrow also kill . The previously collect stem cell infused patient rescue bone marrow allow healthy blood cell re-populate grow bone marrow . Initial study use drug etoposide along carboplatin thiotepa high dose chemotherapy . Patients severe side effect , especially severe mouth-sores , think mainly due etoposide , patient die side effect . Recent study show new drug , temozolomide , active type brain tumor . When give single drug child solid tumor , side effect consider tolerable . Temozolomide give mouth . In study , researcher want give high dose chemotherapy include drug temozolomide place etoposide , along thiotepa carboplatin . Patients give stem cell back rescue bone marrow chemotherapy . A preliminary trial use new drug combination perform show patient tolerate drug combination , even high dos use protocol . Another drug use pediatric cancer treatment call 13-cis-retinoic acid . This drug closely related vitamin A . It take mouth . Cancer cell immature cell `` grown '' adult cell work body . 13-cis-retinoic acid think act type cancer cell make mature cell function body . It also show laboratory cause brain tumor cell undergo apoptosis . It use type pediatric cancer research begin use treatment recurrent brain tumor . In study researcher want give 13-cis-retinoic acid 6 month recover high dose chemotherapy stem cell rescue .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>1 . Patients recurrent refractory medulloblastoma/PNET , CNS germ cell tumor , ependymomas , AT/RT , high grade glioma malignant brain tumor . Brainstem gliomas eligible residual disease &lt; 1.5cc patient decadron . 2 . Patients must recurrent refractory disease follow least one prior course therapy must minimal residual disease define &lt; 1.5 cm2 enhancement . Patients + CSF cytology , linear fine nodular leptomeningeal disease eligible . 3 . Adequate hematologic , renal , liver , cardiac function demonstrate laboratory value perform within 21 day , inclusive , prior administration temozolomide . 4 . Patients must adequate number autologous stem cell available define minimum 2 x 106 CD 34+ cells/kg preferably least 5 x 106 CD 34+ cells/kg . 1 . Previous myeloablative therapy 2 . Frequent vomit medical condition could interfere oral medication intake ( e.g. , partial bowel obstruction ) 3 . Previous concurrent malignancy sit exception surgically cure carcinoma insitu cervix basal squamous cell carcinoma skin . Patients prior malignancy require antitumor treatment within precede 24 month eligible .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Recurrent refractory medulloblastoma/PNET</keyword>
	<keyword>CNS germ cell tumor</keyword>
	<keyword>Ependymomas</keyword>
	<keyword>AT/RT</keyword>
	<keyword>High grade glioma</keyword>
	<keyword>Other malignant brain tumor</keyword>
</DOC>